From an immune standpoint, our results showed that the 2LPAPI medicine slightly increased the secretion of IL-6, IFN-γ, and IP-10—the three cytokines involved in the host immune responses against viral infections—in HPV16(L1)-treated PBMCs. This evidence concerns the gene CXCL10 and viral infectious disease.